Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Time to Sell?

Key Points

• Shares gapped down: Merck KGaA opened at $130.366 after closing at $136.37 and last traded around $130.374 on very light volume (130 shares), with the report noting the stock was down about 0.2%.
• Valuation and technicals: The company has a market cap of $17.59 billion and a P/E of 20.78 with modest leverage (debt/equity 0.27), and the stock is trading below its 50-day ($138.50) and 200-day ($139.47) simple moving averages.
• Company profile: Merck KGaA is a long-established, family-controlled German multinational in chemicals and pharmaceuticals, operating across multiple regions through three main business units.

Shares of Merck KGaA (OTCMKTS:MKGAF - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $136.37, but opened at $130.3660. Merck KGaA shares last traded at $130.3740, with a volume of 130 shares trading hands.

Merck KGaA Stock Down 0.2%

The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market cap of $17.59 billion, a PE ratio of 20.78 and a beta of 0.96. The firm has a fifty day simple moving average of $138.50 and a 200 day simple moving average of $139.47.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company's operations are organized mainly into three businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.